New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 12, 2013
05:55 EDTUBS, UBS, LAZ, LAZ, ED, ED, BLK, BLK, MRK, MRK, T, T, NYX, NYX, CPB, CPB, HES, HES, JNJ, JNJ, INTC, INTC, AA, AA, SAN, SANCapital Link to host a forum
Annual CSR Forum: CSR & IR--Maximizing Shareholder Value will be held in New York on March 13.
News For UBS;AA;INTC;JNJ;HES;CPB;NYX;T;MRK;BLK;ED;LAZ;SAN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>
December 8, 2014
07:01 EDTMRKMerck to acquire Cubist for $102 per share in cash, or $9.5B
Subscribe for More Information
07:00 EDTMRKMerck to acquire Cubist for $102 per share in cash
Subscribe for More Information
December 7, 2014
16:29 EDTMRKMerck in discussions to buy Cubist for $7B, Bloomberg reports
Subscribe for More Information
14:54 EDTJNJIMBRUVICA data suggests promise in multiple myeloma
Subscribe for More Information
12:58 EDTMRKMerck presents KEYTRUDA data at ASH
Subscribe for More Information
December 5, 2014
06:38 EDTAAAlcoa Micromill unveils automotive alloy that is 40% more formable, 30% stronger
Alcoa unveiled breakthrough manufacturing technology, the Alcoa Micromill, that will manufacture the most advanced aluminum sheet on the market. Micromill produces automotive alloy that is 40% more formable and 30% stronger than incumbent aluminum, while meeting stringent automotive surface quality requirements. Alcoa Micromill reduces the time to transform molten metal into aluminum coil from 20 days to 20 minutes. Alcoa has secured a strategic development customer, and from its pilot Micromill facility in San Antonio, TX, has also conducted successful customer trials. Those trials have validated the Micromill materialís unique characteristics, surface quality for exterior panels and overall performance. Alcoa is qualifying the material for use in next-generation automotive platforms.
06:01 EDTTTechNet: Combined AT&T/DirecTV will increase broadband development
Subscribe for More Information
December 4, 2014
11:23 EDTJNJAppeals court reverses patent ruling in favor of J&J unit over Covidien
Ethicon Endo-Surgery, a Johnson & Johnson (JNJ) company, appealed a district court judgment regarding certain asserted patent claims of Tyco Healthcare. The appeals court affirmed-in-part, reversed-in-part, and vacated-in-part the prior judgment, because the lower courtís 102(g) findings were correct, but its 103 determination was improper, "including its decision to exclude the 102(g) prior art from the obviousness analysis," the court stated. In 2007, Tyco Healthcare changed its name to Covidien (COV). Reference Link
10:08 EDTBLK, AAOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:01 EDTJNJVA negotiated $594 per dose price for Gilead HCV treatment
A Veterans Health Administration official told a Senate committee yesterday that Veterans' Affairs has "moved rapidly to deploy new, more effective, less toxic HCV treatments and has been able to negotiate significant discounts for these newer therapies." The agency negotiated a price of $594 per dose for Gilead's (GILD) Hepatitis C virus drug Sofosbuvir, below the commercial price of $1,000 per dose, VHA Chief Consultant for Pharmacy Benefits Management Michael Valentino told the Senate's Committee on Veterans' Affairs. The agency also received a $413 per dose price for Johnson & Johnson's (JNJ) Simeprevir, below the commerical price of $790. The VA has approximately 174,000 veterans in care with HCV, making it the largest single HCV provider in the U.S., Valentino pointed out. He added, "Like the rest of the country, VA has treated only a portion of Veterans for HCV because treatment and cures have been difficult to achieve due to low efficacy and high toxicity of standard drug therapies." Reference Link
07:06 EDTAAAlcoa initiated with an Outperform at Wells Fargo
Subscribe for More Information
06:38 EDTINTCIntel to spend $1.6B to upgrade China factory, Reuters says
Subscribe for More Information
05:30 EDTBLKBlackRock initiated with an Equal Weight at Barclays
Target $385.
December 3, 2014
10:50 EDTTFCC restarts clock on Time Warner Cable/Comcast and AT&T/DirecTV deals
Subscribe for More Information
10:08 EDTJNJJ&J hires Goldman to explore sale of Splenda brand, Reuters says
Subscribe for More Information
09:45 EDTJNJJohnson & Johnson hires bank to explore sale of Splenda brand, Reuters says
09:35 EDTJNJActive equity options trading
Subscribe for More Information
08:10 EDTTDISH downgraded to Sell with $67 target at Wunderlich
Wunderlich downgraded DISH (DISH) to Sell from Hold saying it sees only a 30% chance of all the company's spectrum getting monetized in 2015. Further, Wunderlich believes spectrum owned by Verizon (VZ) and AT&T (T) is worth more than DISH's spectrum, making auction valuation extrapolations "tricky." The firm raised its price target for DISH shares to $67 from $60.
08:06 EDTINTCIntel, Luxottica announce multiyear collaboration for wearable tech
Subscribe for More Information
07:19 EDTBLKNYSSA to hold a conference
Systemic Risk Conference: What Are the Odds of Financial Collapse? is being held at NYSSA New York Conference Center on December 3 with webcasted presentations to begin at 9 am; not all presentations may be webcasted. Webcast Link
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use